• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,496
307
260
201
120

COUNTRY

85
40
38
36
36

CATEGORIES

  • 1,287
  • 694
  • 278
  • 270
  • 239
  • 197
  • 156
  • 137
  • 113
  • 97
  • 97
  • 53
  • 41
  • 40
  • 38
  • 35
  • 31
  • 26
  • 24
  • 18
  • 13
  • 9
  • 9
  • 9
  • 9
  • 7
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

859
1,767
2,785
3,845

PUBLISHED

46
233
863
3,845

PRODUCT TYPE

3,650
158
30
6
1

Search "Company Analysis - Novartis AG" returned 3,845 results.

PRODUCT TITLE

Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review

Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

April 2014
FROM
Novartis AG Company Profile - Business Description, Strategies, SWOT and Financial Analysis Novartis AG Company Profile - Business Description, Strategies, SWOT and Financial Analysis - Product Thumbnail Image

Novartis AG Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Novartis AG Company Profile” is a comprehensive report on Novartis AG. The report provides complete information on the operations, organization structure and financial information details of the company....

October 2014
FROM

Novartis AG (NOVN) - Product Pipeline Analysis, 2014 Update

Summary Novartis AG (Novartis) is a healthcare solutions company. It undertakes the discovery, development and commercialization of a wide range of novel and generic products across various therapeutic...

May 2014
FROM
Novartis AG: Corporate Analysis Novartis AG: Corporate Analysis - Product Thumbnail Image

Novartis AG: Corporate Analysis

This company profile is a premium company information product offering an unmatched depth and breadth of content. It analyzes the strategic positioning of the company - how the company has evolved and...

July 2010
FROM
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM
Novartis AG - Product Pipeline Review - 2013 Novartis AG - Product Pipeline Review - 2013 - Product Thumbnail Image

Novartis AG - Product Pipeline Review - 2013

Novartis AG – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Novartis AG - Product Pipeline Review - 2013” provides data on the Novartis AG’s research and development...

April 2013
FROM
Novartis AG - Product Pipeline Review - 2012 Novartis AG - Product Pipeline Review - 2012 - Product Thumbnail Image

Novartis AG - Product Pipeline Review - 2012

Novartis AG – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Novartis AG - Product Pipeline Review - 2012” provides data on the Novartis AG’s research and development...

November 2012
FROM

Novartis AG - SWOT, Strategy and Corporate Finance Report

Novartis AG - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

June 2013
FROM
Novartis AG - Strategy and SWOT Report Novartis AG - Strategy and SWOT Report - Product Thumbnail Image

Novartis AG - Strategy and SWOT Report

Novartis AG - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

September 2014
FROM
Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis - Product Thumbnail Image

Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis

The global pharmaceutical industry is expected to reach $1,241 billion by 2016, growing at a CAGR of 5 7% The fragmented market has observed some changes in the competitive landscape during the last...

December 2012
FROM

US OTC Pharmaceutical Market Guide

The US OTC industry is expected to have a market value of $31 9 billion by the end of 2014 In this reserach report, you'll learn about the U S OTC Pharmaceutical Market's competitive landscape, market...

November 2012
FROM
U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018 U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018 - Product Thumbnail Image

U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018

This report helps to identify factors, which will be the driving force behind the U S vaccine market and sub-markets in the next six years The report provides extensive analysis of the US vaccine industry,...

September 2012
FROM

Novartis AG - Product Pipeline Review - 2014

Novartis AG - Product Pipeline Review - 2014 Summary This, ‘Novartis AG - Product Pipeline Review - 2014’, provides an overview of the Novartis AG’s pharmaceutical research and development focus. This...

September 2014
FROM
Austria Vitamins and Dietary Supplements Market, 2010-2012 Austria Vitamins and Dietary Supplements Market, 2010-2012 - Product Thumbnail Image

Austria Vitamins and Dietary Supplements Market, 2010-2012

The total market size for dietary supplements and vitamins in Austria is estimated to reach about $200 million for 2008 (exchange rate $1 = EUR 0 71) Austrians are prone to add vitamin supplements to...

September 2010
FROM
Novartis AG Nov 12 Novartis AG Nov 12 - Product Thumbnail Image

Novartis AG Nov 12

Abstract Positive track record of above-industry-average growth in pharmaceuticals. Well-diversified product portfolio. Manageable patent expiration schedule. History of significant free cash flow...

November 2012

Novartis Medical Nutrition Market Share Analysis

Novartis Medical Nutrition Market Share Analysis Summary Our new report, “Novartis Medical Nutrition Market Share Analysis” provides in-depth information on Novartis’s market position in the different...

October 2010
FROM
The Top 50 European Manufacturers of Orthopaedic Implants The Top 50 European Manufacturers of Orthopaedic Implants - Product Thumbnail Image

The Top 50 European Manufacturers of Orthopaedic Implants

Did you know? - Approximately 8 out of 10 people experience severe low back pain at least once in their life - 40% of the population over 70 in the industrialised world suffer from osteoarthritis of...

January 2012
FROM
Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture (World) Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture (World) - Product Thumbnail Image

Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture (World)

Among the largest pharmaceutical companies, both GlaxoSmithKline Plc and Novartis AG are global leaders in consumer health. While manufacturing disruptions and unfavourable market conditions in key...

September 2014
FROM
Brazil Pharmaceutical Market Analysis, 2010-2014 Brazil Pharmaceutical Market Analysis, 2010-2014 - Product Thumbnail Image

Brazil Pharmaceutical Market Analysis, 2010-2014

Having displayed quite healthy growth rates in the years 2005-2008 the Brazil pharmaceuticals market is expected to decelerate slightly in 2009 and stabilize at the level of 7.2% annually till 2014. The...

August 2010
FROM
MorphoSys AG - Product Pipeline Review - 2012 MorphoSys AG - Product Pipeline Review - 2012 - Product Thumbnail Image

MorphoSys AG - Product Pipeline Review - 2012

MorphoSys AG – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “MorphoSys AG - Product Pipeline Review - 2012” provides data on the MorphoSys AG’s research and...

August 2012
FROM
Loading Indicator

Our Clients

Our clients' logos